Alcon Inc. (ALC) Financials
ALC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 29.6 billion | 9.0 billion |
| 2023-09-30 | 29.3 billion | 9.2 billion |
| 2023-06-30 | 29.2 billion | 9.3 billion |
| 2023-03-31 | 29.2 billion | 9.4 billion |
ALC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 109.4 million | ? |
| 2023-09-30 | 363.8 million | 35.0 million |
| 2023-06-30 | 208.0 million | 34.0 million |
| 2023-03-31 | -44.5 million | 40.0 million |
ALC Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 450.0 million |
| 2023-09-30 | 196.9 million |
| 2023-06-30 | 169.0 million |
| 2023-03-31 | 175.8 million |
ALC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 1.1 billion | - | 406.0 million |
| 2023-09-30 | 1.1 billion | - | - |
| 2023-06-30 | 660.4 million | - | - |
| 2023-03-31 | 887.1 million | - | - |
ALC Shares Outstanding
ALC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 370.0 million | 219.2 million | 794.0 million | - |
| 2023-09-30 | 137.9 million | 201.0 million | 798.0 million | - |
| 2023-06-30 | 117.0 million | 217.0 million | 832.0 million | - |
| 2023-03-31 | 130.4 million | 202.0 million | 785.0 million | - |
ALC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.5 billion | 1.1 billion |
| 2023-09-30 | 2.3 billion | 1.0 billion |
| 2023-06-30 | 2.4 billion | 1.1 billion |
| 2023-03-31 | 2.4 billion | 1.0 billion |
ALC
Price: $78.77
Dividend Yield: 0.00%
Forward Dividend Yield: 0.69%
Payout Ratio: 59.93%
Dividend Per Share: 0.55 USD
Earnings Per Share: 1.96 USD
P/E Ratio: 84.84
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 354364
Ebitda: 1.3 billionMarket Capitalization: 40.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 4